Genetic Factors and Bladder Cancer Risk
Author Information
Author(s): McGrath Monica, Michaud Dominique, De Vivo Immaculata
Primary Institution: Harvard School of Public Health
Hypothesis
Do genetic polymorphisms in GSTT1, GSTM1, NAT1, and NAT2 genes influence bladder cancer risk in men and women?
Conclusion
The study found no statistically significant associations between the genetic polymorphisms and bladder cancer risk, although some trends were noted.
Supporting Evidence
- Cigarette smoking is a known risk factor for bladder cancer.
- Polymorphisms in detoxifying enzymes may influence cancer risk.
- No significant associations were found between the studied genetic variants and bladder cancer.
Takeaway
This study looked at how certain genes might affect the risk of getting bladder cancer, but it didn't find strong evidence that they do.
Methodology
The study used two nested case-control studies with a total of 217 bladder cancer cases and 526 matched controls, assessing genetic polymorphisms and smoking status.
Limitations
The study had a small sample size, which limited its power to detect minor to moderate associations.
Participant Demographics
The study included both men and women, with specific focus on Caucasian populations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website